Yipinhong Pharmaceutical Co Ltd Class A (300723) - Total Assets

Latest as of March 2026: CN¥4.70 Billion CNY ≈ $687.40 Million USD

Based on the latest financial reports, Yipinhong Pharmaceutical Co Ltd Class A (300723) holds total assets worth CN¥4.70 Billion CNY (≈ $687.40 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore how well can Yipinhong Pharmaceutical Co Ltd Class A service its debt to assess how comfortably operating cash covers total debt obligations.

Yipinhong Pharmaceutical Co Ltd Class A - Total Assets Trend (2013–2025)

This chart illustrates how Yipinhong Pharmaceutical Co Ltd Class A's total assets have evolved over time, based on quarterly financial data. See 300723 net asset value for net asset value and shareholders' equity analysis.

Yipinhong Pharmaceutical Co Ltd Class A - Asset Composition Analysis

Current Asset Composition (December 2025)

Yipinhong Pharmaceutical Co Ltd Class A's total assets of CN¥4.70 Billion consist of 27.2% current assets and 72.8% non-current assets.

Asset Category	Amount (CNY)	% of Total Assets
Cash & Equivalents	CN¥0.00	12.8%
Accounts Receivable	CN¥205.33 Million	5.1%
Inventory	CN¥215.91 Million	5.3%
Property, Plant & Equipment	CN¥0.00	0.0%
Intangible Assets	CN¥447.63 Million	11.1%
Goodwill	CN¥255.94K	0.0%

Asset Composition Trend (2013–2025)

This chart illustrates how Yipinhong Pharmaceutical Co Ltd Class A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Yipinhong Pharmaceutical Co Ltd Class A (300723) total market value.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Yipinhong Pharmaceutical Co Ltd Class A's current assets represent 27.2% of total assets in 2025, a decrease from 37.4% in 2013.
Cash Position: Cash and equivalents constituted 12.8% of total assets in 2025, up from 7.0% in 2013.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, a decrease from 22.0% in 2013.
Asset Diversification: The largest asset category is intangible assets at 11.1% of total assets.

Yipinhong Pharmaceutical Co Ltd Class A Competitors by Total Assets

Key competitors of Yipinhong Pharmaceutical Co Ltd Class A based on total assets are shown below.

Company	Country	Total Assets
Takeda Pharmaceutical Company Limited F:TKDA	Germany	€15.41 Trillion
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	China	CN¥19.57 Billion
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	China	CN¥2.30 Billion
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	China	CN¥8.59 Billion
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	China	CN¥925.41 Million
Jw Pharmac KO:001060	Korea	₩605.27 Billion
Kamada TA:KMDA	Israel	ILA377.21 Million
Samjin Pharm KO:005500	Korea	₩449.14 Billion

Yipinhong Pharmaceutical Co Ltd Class A - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.45	1.13	2.19
Quick Ratio	1.30	0.98	2.00
Cash Ratio	0.00	0.00	0.00
Working Capital	CN¥644.10 Million	CN¥235.84 Million	CN¥769.03 Million

Yipinhong Pharmaceutical Co Ltd Class A - Advanced Valuation Insights

This section examines the relationship between Yipinhong Pharmaceutical Co Ltd Class A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	9.53
Latest Market Cap to Assets Ratio	0.57
Asset Growth Rate (YoY)	-8.2%
Total Assets	CN¥4.04 Billion
Market Capitalization	$2.32 Billion USD

Valuation Analysis

Below Book Valuation: The market values Yipinhong Pharmaceutical Co Ltd Class A's assets below their book value (0.57x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Yipinhong Pharmaceutical Co Ltd Class A's assets decreased by 8.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Yipinhong Pharmaceutical Co Ltd Class A (2013–2025)

The table below shows the annual total assets of Yipinhong Pharmaceutical Co Ltd Class A from 2013 to 2025.

Year	Total Assets	Change
2025-12-31	CN¥4.04 Billion ≈ $591.51 Million	-8.22%
2024-12-31	CN¥4.40 Billion ≈ $644.46 Million	-0.03%
2023-12-31	CN¥4.41 Billion ≈ $644.63 Million	+7.49%
2022-12-31	CN¥4.10 Billion ≈ $599.73 Million	+10.64%
2021-12-31	CN¥3.70 Billion ≈ $542.07 Million	+72.69%
2020-12-31	CN¥2.15 Billion ≈ $313.90 Million	+19.52%
2019-12-31	CN¥1.79 Billion ≈ $262.64 Million	+0.78%
2018-12-31	CN¥1.78 Billion ≈ $260.61 Million	+20.18%
2017-12-31	CN¥1.48 Billion ≈ $216.85 Million	+96.98%
2016-12-31	CN¥752.32 Million ≈ $110.09 Million	+19.31%
2015-12-31	CN¥630.56 Million ≈ $92.27 Million	-14.07%
2014-12-31	CN¥733.80 Million ≈ $107.38 Million	+78.42%
2013-12-31	CN¥411.27 Million ≈ $60.18 Million	--

About Yipinhong Pharmaceutical Co Ltd Class A

SHE:300723 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.32 Billion

CN¥15.85 Billion CNY

Market Cap Rank

#5606 Global

#1009 in China

Share Price

CN¥35.08

Change (1 day)

-0.62%

52-Week Range

CN¥29.56 - CN¥73.63

All Time High

CN¥80.53